Skip to content
healthcare.dev

Gabapentin

NDC 69097-812, Gabapentin, tablet, from Cipla USA Inc..

Product NDC
69097-812
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202764
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN600 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
69097-812-026909708120230 TABLET in 1 BOTTLE (69097-812-02)
69097-812-0769097081207100 TABLET in 1 BOTTLE (69097-812-07)
69097-812-1269097081212500 TABLET in 1 BOTTLE (69097-812-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7c3ac86f-b8f7-42bf-942a-db854d946e54

Use it

Look up 69097-812 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.